文献速递消化内镜消化道肿瘤与早癌

虚拟现实干预提高结肠镜检查护理质量:一项混合1型随机对照试验

Virtual reality intervention to improve quality of care during colonoscopy: a hybrid type 1 randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2024-06-06

这项混合1型实效性实施平行随机对照开放标签试验将50例患者按1:1随机分入虚拟现实(VR)组或对照组,评估VR在结肠镜检查中减轻疼痛、焦虑、不适及减少镇静药物使用和提高满意度的效果。结果显示VR组疼痛(P=0.043)和不适(P<0.0001)显著更低,无镇静完成结肠镜检查数更多(P=0.003),满意度更高(P=0.032)。实施的主要障碍为VR内容设计不充分。

要点

  • VR组结肠镜检查中疼痛(P=0.043)与不适(P<0.0001)显著低于对照组。
  • VR组无镇静完成结肠镜检查数显著多于对照组(P=0.003)。
  • VR组满意度显著高于对照组(P=0.032)。

核心结论

  • VR可作为非药物方法用于结肠镜检查中的疼痛管理及克服焦虑和不适。
  • VR可提高患者满意度并减少镇静药物需求,从而有潜力促进患者配合与依从并提高筛查性结肠镜检查率。

研究设计与样本

  • 采用混合1型实效性实施平行随机对照开放标签试验,50例患者按1:1随机分入VR组或对照组。
  • 在结肠镜检查前、中、后评估实效性(疼痛、焦虑、不适、药物使用、满意度)和实施(覆盖、采纳、实施、维持)结局。
  • 临床试验注册号为NCT05723861。

主要发现

  • VR组报告的检查中疼痛显著低于对照组(P=0.043)。
  • VR组报告的检查中不适显著低于对照组(P<0.0001)。
  • VR组无镇静完成结肠镜检查数显著多于对照组(P=0.003)。
  • VR组满意度显著高于对照组(P=0.032)。
  • 实施与维持VR干预的主要障碍为VR内容设计不充分;工作人员最担忧患者沟通改变、职责不清、工作量增加及患者安全;患者表示愿意重复使用VR眼镜并向其他患者推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Effective management of patients' pain, anxiety, and discomfort during colonoscopy is crucial for successful completion of the procedure, patient adherence to follow-up examinations, and patient satisfaction. Virtual reality (VR) interventions, as a nonpharmacologic and innovative solution, have demonstrated promising results in managing these outcomes. Nevertheless, there is limited evidence on their effectiveness and implementation. This trial aimed to test clinical effectiveness and identify factors to facilitate the implementation of VR during colonoscopy. METHODS: A hybrid type 1 effectiveness implementation, parallel randomized controlled, open-label trial was conducted. Fifty patients were randomized (1:1) to a VR or a control group. The effectiveness (pain, anxiety, discomfort, medication use, and satisfaction) and implementation (reach, adoption, implementation, and maintenance) outcomes were assessed before, during, and after colonoscopy. RESULTS: Patients in the VR group reported significantly lower pain (P = .043) and discomfort (P <.0001) during colonoscopy, had a higher number of completed colonoscopies without sedation (P = .003), and showed higher satisfaction (P = .032). The major barrier to the implementation and maintenance of the VR intervention was inadequate VR content design. Staff were most worried about altered patient communications, unclear responsibilities, increasing workload, and patient safety. Patients expressed willingness to reuse VR glasses and to suggest them to other patients. CONCLUSIONS: VR can be used as a nonpharmacologic method for pain management and for overcoming anxiety and discomfort during colonoscopy. VR can improve patients' satisfaction and diminish the need for sedative medications; accordingly, it has the potential to promote cooperation and compliance among patients and increase screening colonoscopy rates. (Clinical trial registration number: NCT05723861.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Shamali M, Vilmann P, Johansen NR, et al. Virtual reality intervention to improve quality of care during colonoscopy: a hybrid type 1 randomized controlled trial. Gastrointest Endosc. 2024. PMID: 38851457. doi:10.1016/j.gie.2024.05.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。